Gene · 407027
Papers1,838
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,838
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrated analysis of miRNA-mRNA expression of newly emerging swine H3N2 influenza virus cross-species infection with tree shrews. | Virol J | 2024 | 38178220 | PubTator, text mining | PubMed |
| Construct dysregulated miRNA-mRNA interaction networks to conjecture possible pathogenesis for Stomach adenocarcinomas. | Cancer Biomark | 2024 | 38108345 | PubTator, text mining | PubMed |
| Biological, diagnostic and therapeutic implications of exosomes in glioma. | Cancer Lett | 2024 | 38092145 | PubTator, text mining | PubMed |
| Extracellular vesicle-encapsulated microRNA-296-3p from cancer-associated fibroblasts promotes ovarian cancer development through regulation of the PTEN/AKT and SOCS6/STAT3 pathways. | Cancer Sci | 2024 | 37972389 | PubTator, text mining | PubMed |
| MicroRNA-mediated Regulation of LDL Receptor: Biological and Pharmacological Implications. | Curr Med Chem | 2024 | 37026494 | PubTator, text mining | PubMed |
Comprehensive analysis of microRNA expression in lumbar facet joint capsules and synovium of patients with osteoarthritis: Comparison between early-stage and late-stage osteoarthritis samples from a single individual. | J Orthop Sci | 2024 | 36781308 | PubTator, text mining | PubMed |
| The role of miRNAs in T helper cell development, activation, fate decisions and tumor immunity. | Front Immunol | 2023 | 38264670 | PubTator, text mining | PubMed |
| Uncovering transcriptomic biomarkers for enhanced diagnosis of methamphetamine use disorder: a comprehensive review. | Front Psychiatry | 2023 | 38260797 | PubTator, text mining | PubMed |
| Functional and Potential Therapeutic Implication of MicroRNAs in Pancreatic Cancer. | Int J Mol Sci | 2023 | 38139352 | PubTator, text mining | PubMed |
| Aging and Metabolic Reprogramming of Adipose-Derived Stem Cells Affect Molecular Mechanisms Related to Cardiovascular Diseases. | Cells | 2023 | 38132104 | PubTator, text mining | PubMed |
| An updated landscape on nanotechnology-based drug delivery, immunotherapy, vaccinations, imaging, and biomarker detections for cancers: recent trends and future directions with clinical success. | Discov Nano | 2023 | 38112935 | PubTator, text mining | PubMed |
| The Clinical Significance of MicroRNAs in Colorectal Cancer Signaling Pathways: A Review. | Glob Med Genet | 2023 | 38025193 | PubTator, text mining | PubMed |
| The Connection between MiR-122 and Lymphocytes in Patients Receiving Treatment for Chronic Hepatitis B Virus Infection. | Microorganisms | 2023 | 38004743 | PubTator, text mining | PubMed |
| Molecular Networks of Platinum Drugs and Their Interaction with microRNAs in Cancer. | Genes (Basel) | 2023 | 38003016 | PubTator, text mining | PubMed |
| miRNA Expression Patterns in Early- and Late-Stage Prostate Cancer Patients: High-Throughput Analysis. | Biomedicines | 2023 | 38002073 | PubTator, text mining | PubMed |
| Dysregulation of Non-Coding RNAs: Roles of miRNAs and lncRNAs in the Pathogenesis of Multiple Myeloma. | Noncoding RNA | 2023 | 37987364 | PubTator, text mining | PubMed |
| In silico analysis of prognostic and diagnostic significance of target genes from prostate cancer cell lines derived exomicroRNAs. | Cancer Cell Int | 2023 | 37978493 | PubTator, text mining | PubMed |
A Retrospective Exploratory Analysis for Serum Extracellular Vesicles Reveals APRIL (TNFSF13), CXCL13, and VEGF-A as Prognostic Biomarkers for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer. | Int J Mol Sci | 2023 | 37958571 | PubTator, text mining | PubMed |
| MicroRNA Landscape in Endometrial Carcinomas in an Asian population: Unraveling Subtype-Specific Signatures. | Cancers (Basel) | 2023 | 37958433 | PubTator, text mining | PubMed |
| IRE1-mediated degradation of pre-miR-301a promotes apoptosis through upregulation of GADD45A. | Cell Commun Signal | 2023 | 37946177 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/407027/papers?page=4